keyword
https://read.qxmd.com/read/38639125/-management-and-treatment-of-atrial-fibrillation-in-cancer-patients-an-important-decision-making-hub-in-cardio-oncology
#1
JOURNAL ARTICLE
Giuseppe Boriani, Marta Mantovani, Benedetta Cherubini, Enrico Tartaglia, Niccolò Bonini
No abstract text is available yet for this article.
May 2024: Giornale Italiano di Cardiologia
https://read.qxmd.com/read/38639124/-blitz-af-cancer-study-an-international-observational-research-project-on-patients-with-atrial-fibrillation-and-cancer
#2
JOURNAL ARTICLE
Michele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, Marco Alings, Ronan Collins, Leonardo De Luca, Marcello Di Nisio, Donata Lucci, Domenico Gabrielli, Stefan Janssens, Iris Parrini, Fausto J Pinto, Jose Luis Zamorano, Furio Colivicchi
BACKGROUND: Cancer is an important condition associated with the development of atrial fibrillation (AF). The objectives of the BLITZ-AF Cancer study were to collect real-life information on the clinical profile and use of antithrombotic drugs in patients with AF and cancer to improve clinical management, as well as the evaluation of the association between different antithrombotic treatments (or their absence) and the main clinical events. METHODS: European multinational, multicenter, prospective, non-interventional study conducted in patients with AF (electrocardiographically confirmed) and cancer occurring within 3 years...
May 2024: Giornale Italiano di Cardiologia
https://read.qxmd.com/read/38638883/prevalence-and-outcomes-of-atrial-fibrillation-in-patients-suffering-prostate-cancer-a-national-analysis-in-the-united-states
#3
JOURNAL ARTICLE
Zhemin Pan, Xiao Xu, Xi Xu, Shengyong Wu, Zhensheng Zhang, Suxuan Liu, Zhijian Liu, Boxiang Tu, Chenxin Chen, Yingyi Qin, Jia He
PURPOSE: Although the adverse effects of atrial fibrillation (AF) on cancers have been well reported, the relationship between the AF and the adverse outcomes in prostate cancer (PC) remains inconclusive. This study aimed to explore the prevalence of AF and evaluate the relationship between AF and clinical outcomes in PC patients. METHODS: Patients diagnosed with PC between 2008 and 2017 were identified from the National Inpatient Sample database. The trends in AF prevalence were compared among PC patients and their subgroups...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38619538/coexisting-atrial-fibrillation-and-cancer-time-trends-and-associations-with-mortality-in-a-nationwide-dutch-study
#4
JOURNAL ARTICLE
Qingui Chen, Nienke van Rein, Tom van der Hulle, Julius C Heemelaar, Serge A Trines, Henri H Versteeg, Frederikus A Klok, Suzanne C Cannegieter
BACKGROUND AND AIMS: Coexisting atrial fibrillation (AF) and cancer challenge the management of both. The aim of the study is to comprehensively provide the epidemiology of coexisting AF and cancer. METHODS: Using Dutch nationwide statistics, individuals with incident AF (n = 320 139) or cancer (n = 472 745) were identified during the period 2015-19. Dutch inhabitants without a history of AF (n = 320 135) or cancer (n = 472 741) were matched as control cohorts by demographic characteristics...
April 15, 2024: European Heart Journal
https://read.qxmd.com/read/38618464/gallium-68-labeled-fibroblast-activation-protein-inhibitor-as-an-alternative-radiotracer-to-fluorine-18-fluorodeoxyglucose-a-case-report-of-rare-pulmonary-colloid-adenocarcinoma-diagnosed-by-pet-ct
#5
Areen Mansour, Shahed Obeidat, Dhuha Al-Adhami, Taher Abu Hejleh, Akram Al-Ibraheem
Colloid pulmonary adenocarcinoma represents a seldom encountered neoplasm in clinical practice. The diagnostic process for this rare neoplasm is complicated by its infrequency and the limited understanding of its specific molecular imaging characteristics. We report a 65-year-old male who was diagnosed with pulmonary colloid mucinous cystadenocarcinoma. Fluorine 18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) was conducted for initial evaluation. The scan showed mild 18F-FDG expression at the primary tumor site, and several non-18F-FDG-avid mediastinal and paraesophageal lymph nodes exhibited suspicious morphologic features...
March 2024: Curēus
https://read.qxmd.com/read/38606645/cause-specific-death-in-heart-failure-across-the-ejection-fraction-spectrum-a-comprehensive-assessment-of-over-100%C3%A2-000-patients-in-the-swedish-heart-failure-registry
#6
JOURNAL ARTICLE
Camilla Settergren, Lina Benson, Angiza Shahim, Ulf Dahlström, Tonje Thorvaldsen, Gianluigi Savarese, Lars H Lund, Bahira Shahim
AIM: To assess cause-specific death in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction (HFpEF, HFmrEF, and HFrEF). METHODS AND RESULTS: Data were analysed from the Swedish Heart Failure Registry (SwedeHF) and the National Patient Register of patients enrolled in SwedeHF 2000-2021. Cox proportional hazards regression models were performed and adjusted for age, sex and time period. Among 100 584 patients (23% HFpEF, 23% HFmrEF, 53% HFrEF), median age (interquartile range) was 75 (66-82) and 36% were female...
April 12, 2024: European Journal of Heart Failure
https://read.qxmd.com/read/38595196/use-of-menopausal-hormone-therapy-beyond-age-65-years-and-its-effects-on-women-s-health-outcomes-by-types-routes-and-doses
#7
JOURNAL ARTICLE
Seo H Baik, Fitsum Baye, Clement J McDonald
OBJECTIVES: The study aims to assess the use of menopausal hormone therapy beyond age 65 years and its health implications by types of estrogen/progestogen, routes of administration, and dose strengths. METHODS: Using prescription drug and encounter records of 10 million senior Medicare women from 2007-2020 and Cox regression analyses adjusted for time-varying characteristics of the women, we examined the effects of different preparations of menopausal hormone therapy on all-cause mortality, five cancers, six cardiovascular diseases, and dementia...
April 9, 2024: Menopause: the Journal of the North American Menopause Society
https://read.qxmd.com/read/38593991/new-onset-atrial-fibrillation-is-a-red-flag-to-microvascular-free-tissue-transfer-failure-in-head-and-neck-cancer-patients
#8
JOURNAL ARTICLE
Chia-Hsuan Tsai, Yu Jen Chen, Yu-Chih Lin, Yao-Chang Liu, Huang-Kai Kao, Shih-Hsuan Mao
Background Postoperative new-onset atrial fibrillation (AF) has been shown to be associated with increased surgical morbidity and mortality following cancer ablation surgery. However, evidence on new-onset AF's impact on surgical outcomes in head and neck cancer patients undergoing tumor ablation and microvascular free tissue transfer remains scarce. This study aims to evaluate the association between AF and surgical outcomes in these patients. Methods We enrolled head and neck cancer patients who underwent tumor ablation reconstructed with microvascular free tissue transfer from the National Health Insurance Research Database (NHIRD)...
April 9, 2024: Journal of Reconstructive Microsurgery
https://read.qxmd.com/read/38592136/atrial-fibrillation-catheter-ablation-among-cancer-patients-utilization-trends-and-in-hospital-outcomes
#9
JOURNAL ARTICLE
Gilad Margolis, Ofir Goldhaber, Mark Kazatsker, Ofer Kobo, Ariel Roguin, Eran Leshem
Background: Atrial fibrillation (AF) catheter ablation in cancer patients has been evaluated in very few studies. We aimed to investigate utilization trends and in-hospital outcomes of AF catheter ablation among cancer patients in a large US inpatient registry. Methods: Utilizing the National Inpatient Sample (NIS) database, patients who underwent AF catheter ablation between 2012 and 2019 were identified. Sociodemographic, clinical data, in-hospital procedures and outcomes were collected. Baseline characteristics and in-hospital outcomes were compared between patients with and without cancer...
February 26, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38591349/cardiovascular-events-among-patients-with-prostate-cancer-treated-with-abiraterone-and-enzalutamide
#10
JOURNAL ARTICLE
Onur Baser, Gabriela Samayoa, Archana Dwivedi, Sara AlSaleh, Burhan Cigdem, Erdi Kizilkaya
BACKGROUND AND PURPOSE: There is growing concern about the adverse metabolic and cardiovascular effects of abiraterone acetate (AA) and enzalutamide (ENZ), two standard hormonal therapies for prostate cancer. We analysed the risk of cardiovascular adverse events among patients treated with AA and ENZ. PATIENTS AND METHODS: We used Kythera Medicare data from January 2019 to June 2023 to identify patients with at least one pharmacy claim for AA or ENZ. The index date was the first prescription claim date...
April 9, 2024: Acta Oncologica
https://read.qxmd.com/read/38590475/intralesional-5-fluorouracil-in-the-treatment-of-squamous-cell-carcinoma-in-an-elderly-patient
#11
Stephanie M McDonald, Peter J Neidenbach
Squamous cell carcinoma (SCC) is the second leading form of skin cancer. In the elderly population, surgery may carry more risk and significant morbidity in comparison to less invasive forms of treatment. This case report describes the successful use of intralesional 5-fluorouracil (IL5-FU) to treat cutaneous squamous cell carcinoma (cSCC). A 98-year-old white woman presented in early May 2017 with a 3.5-cm rapidly growing crusted nodule on her left proximal-lateral arm. She had a past medical history of chronic obstructive pulmonary disease, atrial fibrillation, and heart failure...
March 2024: Curēus
https://read.qxmd.com/read/38586603/multimorbidity-trajectories-in-early-adulthood-and-middle-age-findings-from-the-cardia-prospective-cohort-study
#12
JOURNAL ARTICLE
C Barrett Bowling, Richard A Faldowski, Richard Sloane, Carl Pieper, Tyson H Brown, Erin E Dooley, Brett T Burrows, Norrina B Allen, Kelley Pettee Gabriel, Cora E Lewis
BACKGROUND: Multimorbidity research has focused on the prevalence and consequences of multimorbidity in older populations. Less is known about the accumulation of chronic conditions earlier in the life course. METHODS: We identified patterns of longitudinal multimorbidity accumulation using 30 years of data from in-person exams, annual follow-ups, and adjudicated end-points among 4,945 participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study...
2024: J Multimorb Comorb
https://read.qxmd.com/read/38584909/cardiotoxicity-induced-by-capecitabine-and-oxaliplatin-in-gastric-cancer-treatment-a-rare-case-of-cardiac-arrest-and-cardiogenic-shock
#13
JOURNAL ARTICLE
Muhammad Umer Riaz Gondal, John Lemoine, Jared Segal, Zainab Kiyani, Muhammad Ibraiz Bilal, Fawwad Ansari, Brian McCauley
INTRODUCTION: Combination-based adjuvant chemotherapy utilising capecitabine and oxaliplatin is widely used in gastric cancer treatment. Rare but severe cardiac events such as prolonged QT, cardiac arrest and cardiogenic shock can result from their use. CASE DESCRIPTION: A 45-year-old female with gastric adenocarcinoma was started on capecitabine-oxaliplatin chemotherapy one week before presenting to the emergency department with weakness. Blood pressure was 78/56 mmHg, heart rate 140 bpm and oxygen saturation 85%...
2024: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/38576928/guillain-barre-syndrome-following-covid-19-vaccination-a-study-of-70-case-reports
#14
REVIEW
Biki Kumar Sah, Zahra Fatima, Rajan Kumar Sah, Bushra Syed, Tulika Garg, Selia Chowdhury, Bikona Ghosh, Binita Kunwar, Anagha Shree, Vivek Kumar Sah, Anisha Raut
BACKGROUND AND OBJECTIVE: Guillain-Barre syndrome (GBS) has been found to have some interesting association with vaccinations. This paper mainly focuses on exploring different associations between COVID-19 vaccination and GBS. METHODS: Electronic databases such as PubMed, Google Scholar, Cochrane, and Embase were searched using MESH terms for case reports published till 1 August 2023 from which 70 case reports were documented involving 103 individuals from 23 different countries...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38576467/a-case-report-of-recurrent-primary-posterior-mediastinal-perivascular-epithelioid-cell-tumour-compressing-the-right-inferior-pulmonary-vein-atria-and-inferior-vena-cava
#15
Preetham Kumar, Nolan S Maloney, Anees Razzouk, Ramdas G Pai, Padmini Varadarajan
BACKGROUND: Perivascular epithelioid cell tumours (PEComas) are rare soft tissue neoplasms that commonly occur in the uterus, skin, and liver and less commonly in the retroperitoneum, colon, and mediastinum. CASE SUMMARY: A 36-year-old male patient with a history of mediastinal PEComa status post resection, essential hypertension, and atrial fibrillation status post appendage ligation currently not on anticoagulation presented with a 1-week history of fevers, chills, productive cough, chest pain, dyspnoea on exertion, loss of appetite, and general weakness...
April 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38572424/a-review-of-chemotherapeutic-drugs-induced-arrhythmia-and-potential-intervention-with-traditional-chinese-medicines
#16
REVIEW
Weina Li, Xiaozhen Cheng, Guanghui Zhu, Ying Hu, Yunhan Wang, Yueyue Niu, Hongping Li, Aikeremu Aierken, Jie Li, Ling Feng, Guifang Liu
Significant advances in chemotherapy drugs have reduced mortality in patients with malignant tumors. However, chemotherapy-related cardiotoxicity increases the morbidity and mortality of patients, and has become the second leading cause of death after tumor recurrence, which has received more and more attention in recent years. Arrhythmia is one of the common types of chemotherapy-induced cardiotoxicity, and has become a new risk related to chemotherapy treatment, which seriously affects the therapeutic outcome in patients...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38567707/analysis-and-mapping-the-research-landscape-on-patient-centred-care-in-the-context-of-chronic-disease-management
#17
JOURNAL ARTICLE
Waleed M Sweileh
RATIONALE: Patient-centred care has emerged as a transformative approach in managing chronic diseases, aiming to actively involve patients in their healthcare decisions. AIMS AND OBJECTIVES: This study was conducted to analyse and map the research landscape on patient-centred care in the context of chronic disease management. METHODS: This study used Scopus to retrieve the relevant articles. The analysis focused on the growth pattern, highly cited articles, randomised clinical trials, patients and providers perspectives, facilitators and barriers, frequent author keywords, emerging topics, and prolific countries and journals in the field...
April 3, 2024: Journal of Evaluation in Clinical Practice
https://read.qxmd.com/read/38556578/management-of-doac-related-bleeding-in-cancer-patients-a-single-center-case-series
#18
JOURNAL ARTICLE
Sophia Lee, Jeremy A Ross, Ali Zalpour, Jason T Henry, Cristhiam M Rojas Hernandez
Venous thromboembolism (VTE) and stroke carry significant mortality and morbidity in cancer patients. Direct oral anticoagulants (DOACs) have been demonstrated to be effective for the treatment of VTE and prevention of stroke in atrial fibrillation (AF). Bleeding rates are variable and are based on the cancer type and the patient's specific risk factors. There are approved specific antidotes for DOAC-associated bleeding. Other strategies are available for bleeding reversal, including the use of prothrombin complex concentrate (PCC)...
March 31, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38542180/application-of-photodynamic-therapy-in-cardiology
#19
REVIEW
Piotr Wańczura, David Aebisher, Maksymilian Kłosowicz, Angelika Myśliwiec, Klaudia Dynarowicz, Dorota Bartusik-Aebisher
The origins of photodynamic therapy (PDT) date back to 1904. Since then, the amount of research proving PDT and, consequently, its applicability to various disease states has steadily increased. Currently, PDT is mainly used in oncology to destroy cancer cells. It is being worked on for possible use in other medical fields as well, including cardiology. It can be used in the prevention of restenosis, often occurring after vascular surgical interventions, for destroying atherosclerotic plaques and as a new ablative method of ectopic centers in the treatment of atrial fibrillation...
March 11, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38541902/clinical-characteristics-and-incidence-of-hemorrhagic-complications-in-patients-taking-factor-xa-inhibitors-in-spain-a-long-term-observational-study
#20
JOURNAL ARTICLE
Carlos Escobar, Beatriz Palacios, Miriam Villarreal, Martín Gutiérrez, Margarita Capel, Ignacio Hernández, María García, Laura Lledó, Juan F Arenillas
Objective. To analyze the clinical characteristics of patients taking Factor Xa inhibitors (FXai), either direct FXai or enoxaparin (only in active cancer patients), and to estimate the incidence of and risk factors for major bleeding during FXai use. Methods. A retrospective cohort study, which included secondary data from computerized health records of primary care centers and hospitals in seven Spanish Autonomous Communities. Results. 9374 patients were analyzed, with 8972 taking direct FXai and 402 enoxaparin...
March 14, 2024: Journal of Clinical Medicine
keyword
keyword
109862
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.